These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 22701712)
1. GEP100/Arf6 is required for epidermal growth factor-induced ERK/Rac1 signaling and cell migration in human hepatoma HepG2 cells. Hu Z; Du J; Yang L; Zhu Y; Yang Y; Zheng D; Someya A; Gu L; Lu X PLoS One; 2012; 7(6):e38777. PubMed ID: 22701712 [TBL] [Abstract][Full Text] [Related]
2. GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway. Hu Z; Xu R; Liu J; Zhang Y; Du J; Li W; Zhang W; Li Y; Zhu Y; Gu L Exp Cell Res; 2013 Aug; 319(13):1932-1941. PubMed ID: 23747719 [TBL] [Abstract][Full Text] [Related]
3. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. Morishige M; Hashimoto S; Ogawa E; Toda Y; Kotani H; Hirose M; Wei S; Hashimoto A; Yamada A; Yano H; Mazaki Y; Kodama H; Nio Y; Manabe T; Wada H; Kobayashi H; Sabe H Nat Cell Biol; 2008 Jan; 10(1):85-92. PubMed ID: 18084281 [TBL] [Abstract][Full Text] [Related]
4. The guanine nucleotide exchange protein for ADP-ribosylation factor 6, ARF-GEP100/BRAG2, regulates phagocytosis of monocytic phagocytes in an ARF6-dependent process. Someya A; Moss J; Nagaoka I J Biol Chem; 2010 Oct; 285(40):30698-707. PubMed ID: 20601426 [TBL] [Abstract][Full Text] [Related]
5. ARF6 promotes the formation of Rac1 and WAVE-dependent ventral F-actin rosettes in breast cancer cells in response to epidermal growth factor. Marchesin V; Montagnac G; Chavrier P PLoS One; 2015; 10(3):e0121747. PubMed ID: 25799492 [TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein. Sakurai A; Jian X; Lee CJ; Manavski Y; Chavakis E; Donaldson J; Randazzo PA; Gutkind JS J Biol Chem; 2011 Sep; 286(39):34335-45. PubMed ID: 21795701 [TBL] [Abstract][Full Text] [Related]
7. ADP-ribosylation factor 6 regulates glioma cell invasion through the IQ-domain GTPase-activating protein 1-Rac1-mediated pathway. Hu B; Shi B; Jarzynka MJ; Yiin JJ; D'Souza-Schorey C; Cheng SY Cancer Res; 2009 Feb; 69(3):794-801. PubMed ID: 19155310 [TBL] [Abstract][Full Text] [Related]
8. GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis. Hashimoto A; Hashimoto S; Ando R; Noda K; Ogawa E; Kotani H; Hirose M; Menju T; Morishige M; Manabe T; Toda Y; Ishida S; Sabe H PLoS One; 2011; 6(8):e23359. PubMed ID: 21858086 [TBL] [Abstract][Full Text] [Related]
9. Arf nucleotide binding site opener [ARNO] promotes sequential activation of Arf6, Cdc42 and Rac1 and insulin secretion in INS 832/13 β-cells and rat islets. Jayaram B; Syed I; Kyathanahalli CN; Rhodes CJ; Kowluru A Biochem Pharmacol; 2011 Apr; 81(8):1016-27. PubMed ID: 21276423 [TBL] [Abstract][Full Text] [Related]
10. GEP100/ARF6 regulates VEGFR2 signaling to facilitate high-glucose-induced epithelial-mesenchymal transition and cell permeability in retinal pigment epithelial cells. You ZP; Chen SS; Yang ZY; Li SR; Xiong F; Liu T; Fu SH Am J Physiol Cell Physiol; 2019 Jun; 316(6):C782-C791. PubMed ID: 30540496 [TBL] [Abstract][Full Text] [Related]
11. Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation. Li M; Wang J; Ng SS; Chan CY; He ML; Yu F; Lai L; Shi C; Chen Y; Yew DT; Kung HF; Lin MC Cancer; 2009 Nov; 115(21):4959-72. PubMed ID: 19642173 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor-GEP100-Arf6 axis affects the prognosis of lung adenocarcinoma. Oka S; Uramoto H; Shimokawa H; Yamada S; Tanaka F Oncology; 2014; 86(5-6):263-70. PubMed ID: 24902879 [TBL] [Abstract][Full Text] [Related]
13. Endogenous ARF6 interacts with Rac1 upon angiotensin II stimulation to regulate membrane ruffling and cell migration. Cotton M; Boulay PL; Houndolo T; Vitale N; Pitcher JA; Claing A Mol Biol Cell; 2007 Feb; 18(2):501-11. PubMed ID: 17122362 [TBL] [Abstract][Full Text] [Related]
14. 5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation. Magi S; Takemoto Y; Kobayashi H; Kasamatsu M; Akita T; Tanaka A; Takano K; Tashiro E; Igarashi Y; Imoto M Cancer Sci; 2014 Mar; 105(3):290-6. PubMed ID: 24350867 [TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6. Humphries JD; Byron A; Bass MD; Craig SE; Pinney JW; Knight D; Humphries MJ Sci Signal; 2009 Sep; 2(87):ra51. PubMed ID: 19738201 [TBL] [Abstract][Full Text] [Related]
16. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085 [TBL] [Abstract][Full Text] [Related]
17. The EGFR-GEP100-Arf6 pathway in breast cancer: Full invasiveness is not from the inside. Sabe H; Hashimoto S; Morishige M; Hashimoto A; Ogawa E Cell Adh Migr; 2008; 2(2):71-3. PubMed ID: 19262097 [TBL] [Abstract][Full Text] [Related]
18. The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis. Sabe H; Hashimoto S; Morishige M; Ogawa E; Hashimoto A; Nam JM; Miura K; Yano H; Onodera Y Traffic; 2009 Aug; 10(8):982-93. PubMed ID: 19416474 [TBL] [Abstract][Full Text] [Related]
19. ARF6 is required for growth factor- and rac-mediated membrane ruffling in macrophages at a stage distal to rac membrane targeting. Zhang Q; Calafat J; Janssen H; Greenberg S Mol Cell Biol; 1999 Dec; 19(12):8158-68. PubMed ID: 10567541 [TBL] [Abstract][Full Text] [Related]
20. Pals1 functions in redundancy with SMAP1 to inhibit Arf6 in order to prevent Rac1-dependent colorectal cancer cell migration and invasion. Harms J; Lüttgenau SM; Emming C; Guske J; Weber K; Wagner T; Schowe L; Nedvetsky P; Krahn MP Cancer Gene Ther; 2023 Mar; 30(3):497-506. PubMed ID: 36494580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]